for all exposures, there was substantial heterogeneity (all i2 > 75%), partly explained by study design: the magnitude of associations was smaller in prospective versus retrospective studies, and for igfbp-3 the inverse association with prostate cancer risk was seen in retrospective but not prospective studies.